Active material: morfolinoetiltioetoksiʙenzimidazola digidroxlorid
When ATH: N05BX
CCF: Tranquillizer (anxiolytic)
ICD-10 codes (testimony): F10.3, F17, F40, F41.1, F43, F45.3, F48.0, F51.2, I10, i20, J45, K58, M32, N94.3
When CSF: 02.04.05
Manufacturer: OAO Pharmstandard-Leksredstva (Russia)
◊ Pills white or white with Valium a color shade, Valium, chamfered.
| 1 tab. | |
| morfolinoetiltioetoksiʙenzimidazola digidroxlorid | 5 mg |
| -“- | 10 mg |
Excipients: potato starch, microcrystalline cellulose, lactose, povidone, magnesium stearate.
20 PC. – упаковки ячейковые контурные (3) – пачки картонные.
Afoʙazol® – производное 2-меркаптобензимидазола, selective anxiolytic, not belonging to the class of benzodiazepine receptor agonists. It prevents the development of membranozavisimyh changes in GABA-receptor.
The drug has anxiolytic effects with an activating component, not accompanied effect gipnosedativny (sedative effects at the doses detected, in 40-50 times the ED50
for anxiolytic action). There are no muscle relaxant properties of the drug, a negative impact on memory and attention. In applying the drug is not formed drug dependence and withdrawal symptoms do not develop.Effect of the drug is realized mainly in the form of a combination of anxiolytic (protivotrevozhnogo) stimulating and easy (activating) Effects. Reducing or eliminating anxiety (preoccupation, bad feeling, concerns, irritability), tension (puhlyvost, tearfulness, anxiety, inability to relax, insomnia, fear), and, Consequently, somatic (muscle, touch, Cardiovascular, Breathing, gastrointestinal symptoms), vegetative (dry mouth, Sweating, dizziness), Cognitive (difficulty concentrating, hypomnesia) violations observed on 5-7 days of treatment afobazole®. The maximum effect is reached at the end 4 week of treatment and lasts an average period posleterapevticheskom 1-2 of the week.
Especially shows the use of the drug in patients with predominantly asthenic personality traits as alarming suspiciousness, uncertainty, increased vulnerability and emotional lability, propensity to emotional stress reactions. Afoʙazol® non-toxic (LD50 in rats is 1.1 d at ED50 1 mg).
Absorption
Cmax is 0.13 ± 0.073 g / ml.
Distribution
Среднее время удержания препарата в организме – 1.6±0.86 ч. Intensively distributed to well-vascularized organs.
Deduction
T1/2 is 0.82 no.
Anxiety in Adults:
- Generalized anxiety disorder, neurasthenia, adjustment disorder;
- In patients with various somatic (bronchial asthma, Irritable Bowel Syndrome, SLE, CHD, arterial hypertension, Arrhythmia), dermatological and oncological diseases;
- Sleep disorders, associated with anxiety;
- Cardiopsychoneurosis;
- Premenstrual tension;
- Alcohol withdrawal syndrome;
- To facilitate the withdrawal syndrome smoking cessation.
The drug is prescribed inside, postprandial. A single dose of 10 mg; суточная доза – 30 mg, razdelennaya of 3 receiving during the day. The duration of a course of the drug is 2-4 of the week. If necessary, the daily dose can be increased to 60 mg, and the duration of treatment to 3 months.
Maybe: allergic reactions, Individual hypersensitivity.
- Pregnancy;
- Lactation (breast-feeding);
- Up to 18 years;
- Hypersensitivity to the drug.
The drug is contraindicated during pregnancy and lactation (breast-feeding).
–
Symptoms: if a large overdose and intoxication may develop sedation and increased sleepiness without manifestations miorelaxation.
Treatment: as prescribed emergency n / a caffeine-sodium benzoate 20% solution for 1 ml 2-3 times / day.
In an application Afobazol® It has no influence on the effects of ethanol and thiopental.
In an application Afobazol® potentiates the anticonvulsant effect of carbamazepine.
In an application Afobazol® causes increased anxiolytic action of diazepam.
The drug is resolved to application as an agent Valium holidays.
The drug should be stored out of reach of children, dry, dark place at a temperature no higher than 25 ° C. Shelf life - 2 year.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More